Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of Statin
Clinical trial NCT02584504 · COMPLETED
Trial details
- NCT number
- NCT02584504
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-30
- Primary completion
- 2017-04-05
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.